All stock lists
EDGEWELL PERSONAL CARE Co (New York Stock Exchange:EPC)
US · Delayed Price · Currency is USD
Consumer Defensive · Household & Personal Products
$28.74-$0.41 (-1.41%)
Market cap
$1.32B
Insider Score
Health Score
Analyst consensus
Listed since
Mar 27, 2000
Website
Insider Score
––Not scored
EPC Insider Score
Insiders here have filed 8 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
EPC analyst forecast
EPC analyst consensus
Moderate Buy1 ratings
Buy 1 Hold 0 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
EPC 12-month price target
$29.40+2.3% upsideaverage of 5 firms
$35.00High
$21.00Low
Best analysts covering EPC
- Wells Fargo40%success rate · -3.2% avg return · 10 calls
- Canaccord Genuity17%success rate · -9.9% avg return · 6 calls
- RBC Capital0%success rate · -22.1% avg return · 2 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
EPC analyst ratings
Filters
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| RBC Capital | Outperform | $35.00 | +19.3% | Price target | 2026-11-10 | |
| UBS | Neutral | $30.00 | +4.3% | Price target | 2026-10-15 | |
| Wells Fargo | Overweight | $30.00 | +12.7% | Reiterated | 2026-10-05 | |
| Barclays | Equal Weight | $21.00 | +6.1% | Reiterated | 2026-08-07 | |
| RBC Capital | Outperform | $26.00 | +16.4% | Reiterated | 2026-08-06 | |
| UBS | Neutral | $23.00 | +7.0% | Reiterated | 2026-08-06 | |
| Morgan Stanley | Equal Weight | $31.00 | +10.4% | Price target | 2026-08-06 | |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2026-07-07 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-02-10 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2025-11-18 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2025-11-14 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2025-11-14 |
EPC earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-09 | -$0.18 | -$0.16 | $478.2M | $486.8M |
| 2026-05-06 | $0.43 | $0.60 | $518.5M | $519.5M |
| 2026-08-05 | $0.65 | $0.72 | $574.9M | $570.1M |
| 2026-11-12 | $0.77 | $0.78 | $479.9M | $484.1M |
| 2027-02-08Upcoming | -$0.01 | — | $424.5M | — |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.